The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastogrhy

Anesthesia and Analgesia

Volumn 99, Issue 1, 2004, Pages 120-123

  Nielsen, Vance G ^a   Gurley Jr , William Q ^a   Burch, Thomas M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; CALCIUM CHLORIDE; FIBRINOGEN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; DECISION MAKING; DRUG EFFECT; HUMAN; KINETICS; PRIORITY JOURNAL; SHEAR STRENGTH; THROMBOELASTOGRAPHY; YOUNG MODULUS;

EID: 3042662496     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000123012.24871.62     Document Type: Article

References (13)

1. Kettner SC, Panzer OP, Kozek SA, et al. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999;89:580-4.
2. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88: 312-9.
3. Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth 1997;78:175-9.
4. Kettner SC, Gonano C, Seebach F, et al. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg 1998; 86:691-5.
5. Pivalizza EG, Abramson DC, King FS. Thromboelastography with heparinase in orthotopic liver transplantation. J Cardiothorac Vasc Anesth 1998;12:305-8.
6. Mahla E, Lang T, Vicenzi MN, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001;92:572-7.
7. Khurana S, Mattson JC, Westley S, et al. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997;130: 401-11.
8. Greilich PE, Alving BM, Longnecker D, et al. Near-site monitoring of the antiplatelet drug abciximab using the Hemodyne analyzer and modified thrombelastograph. J Cardiothorac Vasc Anesth 1999;13:58-64.
9. Tyler HM. Fibrin crosslinking demonstrated by thrombelastography. Thromb Diath Haemorrh 1969;22:398-400.
10. Schroeder V, Chatterjee T, Kohler H. Influence of blood coagulation factor XIII and FXIII val34leu on plasma clot formation measured by thrombelastography. Thromb Res 2001;104: 467-74.
11. Lauer P, Metzner HJ, Zettlmeibl G, et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-a: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost 2002;88:967-74.
12. Glidden PF, Malaska C, Herring SW. Thromboelastograph assay for measuring the mechanical strength of fibrin sealant clots. Clin Appl Thromb Hemost 2000;6:226-33.
13. Loewy AG, McDonagh J, Mikkola H, et al. Structure and function of factor XIII. In: Colman RW, Hirsh J, Marder VJ, et al., eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott Williams & Wilkins, 2001:233-47.